Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509392 · ClinicalTrials.gov registry record · Phase 4
ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.
A Phase 4 study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
NCT00509392 is a Phase 4 study that has completed, run by Medtronic Endovascular. The registered enrollment target is 69 participants.
The verdict
NCT00509392, a Phase 4 study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
Study Summary
The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.
Interventions
- DEVICE Seg. RF Ablation & ClosureFAST catheter
- DEVICE Endovenous Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00509392
The ClinicalTrials.gov registry entry for NCT00509392 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Seg. RF Ablation & ClosureFAST catheter is the first listed.
NCT00509392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00509392 about?
NCT00509392 is a clinical study titled "ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.". The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.
What is the current status of trial NCT00509392?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2007-03. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00509392?
The interventions under investigation include: Seg. RF Ablation & ClosureFAST catheter (DEVICE), Endovenous Laser (DEVICE).
Who is sponsoring clinical trial NCT00509392?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.